Delivery Order SPE2DB22D3501-SPE2DB26FTL46
Award Date 11/9/25
Potential Completion Date 11/10/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors with a ceiling value of $11,074.20 and a firm fixed price structure. This delivery order, which is expected to be completed by November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors, with a contract ceiling value of $4,383.47. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.06 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 ml pen injections. This firm fixed-price delivery order, awarded on October 31, 2025, with completion targeted for November 3, 2025, represents a purchase of pharmaceutical products to support federal medical supply needs. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $15,944.25 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,743.48 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors. The contract is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $4,839.72 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is expected to be completed by September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens valued at $14,389.65. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was not set-aside and was competitively awarded, demonstrating AmerisourceBergen's capability to meet...
- The Defense Logistics Agency (DLA) awarded a $6,948.03 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award utilized no set-aside designation and represents a competitive procurement for pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $34,983.20 on September 4, 2025, for Zepbound (semaglutide) 5 mg/0.5 mL pens with a completion date of September 5, 2025. This is a firm fixed-price, non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,343.19 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...